KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Operating Margin (2018 - 2025)

Historic Operating Margin for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to 31.73%.

  • Twist Bioscience's Operating Margin rose 73300.0% to 31.73% in Q4 2025 from the same period last year, while for Dec 2025 it was 34.35%, marking a year-over-year increase of 287900.0%. This contributed to the annual value of 36.18% for FY2025, which is 343700.0% up from last year.
  • According to the latest figures from Q4 2025, Twist Bioscience's Operating Margin is 31.73%, which was up 73300.0% from 30.23% recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Operating Margin registered a high of 30.23% during Q3 2025, and its lowest value of 133.13% during Q4 2021.
  • For the 5-year period, Twist Bioscience's Operating Margin averaged around 81.45%, with its median value being 88.82% (2022).
  • In the last 5 years, Twist Bioscience's Operating Margin tumbled by -310000bps in 2021 and then skyrocketed by 778000bps in 2025.
  • Quarter analysis of 5 years shows Twist Bioscience's Operating Margin stood at 133.13% in 2021, then surged by 38bps to 82.28% in 2022, then rose by 20bps to 65.7% in 2023, then skyrocketed by 41bps to 39.05% in 2024, then rose by 19bps to 31.73% in 2025.
  • Its last three reported values are 31.73% in Q4 2025, 30.23% for Q3 2025, and 31.36% during Q2 2025.